Replies to post #344652 on Amarin Corp Plc (AMRN)

[johngnatt]

there is a lot of circumstantial evidence that Amarin talked about in the lawsuit
1. Mention of $1 billion sales
2. telling the generic is equivalent to vascepa (based on FDA guidelines)
3. Removing press releases from website

However, none of these would classify as INDUCING a physician to prescribe generic V.

And even if they infringe, beyond a tiny slap and reminder to correct wrongdoing, an injunction is impossible.